FDA panel rejects Merck bid for over-the-counter cholesterol drug

WASHINGTON - Government advisers on Thursday rejected Merck & Co.'s bid for over-the-counter sales of Mevacor, the granddaddy of the famed cholesterol-lowering drugs....More